Funder: National Institutes of Health (NIH)
Due Dates: February 18, 2026 | June 17, 2026 | February 17, 2027 | June 17, 2027 | February 17, 2028 | June 20, 2028
Funding Amounts: Up to $275,000 direct costs over 2 years; no more than $200,000 in any single year; max project period is 2 years.
Summary: Supports research to enhance clinical trial readiness in rare diseases by validating biomarkers, clinical outcome assessments, or defining disease natural history.
Key Information: Clinical trials are not allowed; focus is on preparatory research for future clinical trials in rare diseases.